268 related articles for article (PubMed ID: 24882037)
1. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats.
Darville N; van Heerden M; Vynckier A; De Meulder M; Sterkens P; Annaert P; Van den Mooter G
J Pharm Sci; 2014 Jul; 103(7):2072-2087. PubMed ID: 24845884
[TBL] [Abstract][Full Text] [Related]
3. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
4. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
Xu Y; Liu X; Lian R; Zheng S; Yin Z; Lu Y; Wu W
Int J Pharm; 2012 Nov; 438(1-2):287-95. PubMed ID: 22989976
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
[TBL] [Abstract][Full Text] [Related]
6. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible riboflavin laurate long-acting injectable nanosuspensions allowing sterile filtration.
Hu X; Lin X; Gu Y; Liu Z; Tang Y; Zhang Y; Chen X; Wang Y; Tang X
Drug Deliv; 2014 Aug; 21(5):351-61. PubMed ID: 24188474
[TBL] [Abstract][Full Text] [Related]
8. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
9. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
Sahu BP; Das MK
Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201
[TBL] [Abstract][Full Text] [Related]
10. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
[TBL] [Abstract][Full Text] [Related]
11. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
12. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
Karakucuk A; Celebi N; Teksin ZS
Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
[TBL] [Abstract][Full Text] [Related]
13. Preparation of azithromycin nanosuspensions by reactive precipitation method.
Hou CD; Wang JX; Le Y; Zou HK; Zhao H
Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
[TBL] [Abstract][Full Text] [Related]
14. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
15. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
[TBL] [Abstract][Full Text] [Related]
16. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions.
Luo Y; Xu L; Tao X; Xu M; Feng J; Tang X
Drug Dev Ind Pharm; 2013 Jul; 39(7):936-46. PubMed ID: 23046250
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
Wang Y; Han X; Wang J; Wang Y
Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
Qiao F; Zhao Y; Mai Y; Guo J; Dong L; Zhang W; Yang J
Planta Med; 2020 May; 86(8):538-547. PubMed ID: 32294789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
